Dr Reddy's Laboratories (BOM:500124) Change In Receivables : ₹-10,283 Mil (TTM As of Mar. 2025)

View and export this data going back to 1992. Start your Free Trial

What is Dr Reddy's Laboratories Change In Receivables?

Dr Reddy's Laboratories's change in receivables for the quarter that ended in Mar. 2025 was ₹1,751 Mil. It means Dr Reddy's Laboratories's Accounts Receivable declined by ₹1,751 Mil from Dec. 2024 to Mar. 2025 .

Dr Reddy's Laboratories's change in receivables for the fiscal year that ended in Mar. 2025 was ₹-10,283 Mil. It means Dr Reddy's Laboratories's Accounts Receivable increased by ₹10,283 Mil from Mar. 2024 to Mar. 2025 .

Dr Reddy's Laboratories's Accounts Receivable for the quarter that ended in Mar. 2025 was ₹90,420 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Dr Reddy's Laboratories's Days Sales Outstanding for the three months ended in Mar. 2025 was 97.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Dr Reddy's Laboratories's liquidation value for the three months ended in Mar. 2025 was ₹9,417 Mil.

Dr Reddy's Laboratories Change In Receivables Historical Data

The historical data trend for Dr Reddy's Laboratories's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Change In Receivables Chart

Dr Reddy's Laboratories Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Change In Receivables

Get a 7-Day Free Trial

2,081.00

-17,012.00

-5,752.00

-8,054.00

-10,283.00

Dr Reddy's Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-1,917.00	-786.00	-3,396.00	-7,852.00	1,751.00

Dr Reddy's Laboratories Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-10,283 Mil.

Dr Reddy's Laboratories (BOM:500124) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Dr Reddy's Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	90420	/	85060	*	91
=	97.00

2. In Ben Graham's calculation of liquidation value, Dr Reddy's Laboratories's accounts receivable are only considered to be worth 75% of book value:

Dr Reddy's Laboratories's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	61051	-	154992	+	0.75 * 90420	+	0.5 * 71085
=	9,417

Dr Reddy's Laboratories Change In Receivables Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (BOM:500124) » Definitions » Change In Receivables

Traded in Other Exchanges

RDY:USA DRREDDY:India RDDA:Germany RDDA:Germany R1DY34:Brazil

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories Headlines

No Headlines